96 related articles for article (PubMed ID: 14671152)
1. Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance.
Marchesini G; Pagotto U; Bugianesi E; De Iasio R; Manini R; Vanni E; Pasquali R; Melchionda N; Rizzetto M
J Clin Endocrinol Metab; 2003 Dec; 88(12):5674-9. PubMed ID: 14671152
[TBL] [Abstract][Full Text] [Related]
2. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
3. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
[TBL] [Abstract][Full Text] [Related]
4. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
[TBL] [Abstract][Full Text] [Related]
5. The associations between plasma adiponectin, ghrelin levels and cardiovascular risk factors.
Choi KM; Lee J; Lee KW; Seo JA; Oh JH; Kim SG; Kim NH; Choi DS; Baik SH
Eur J Endocrinol; 2004 May; 150(5):715-8. PubMed ID: 15132729
[TBL] [Abstract][Full Text] [Related]
6. Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes.
Giménez-Palop O; Giménez-Pérez G; Mauricio D; Berlanga E; Potau N; Vilardell C; Arroyo J; González-Clemente JM; Caixàs A
Eur J Endocrinol; 2005 Jul; 153(1):73-9. PubMed ID: 15994748
[TBL] [Abstract][Full Text] [Related]
7. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls.
McLaughlin T; Abbasi F; Lamendola C; Frayo RS; Cummings DE
J Clin Endocrinol Metab; 2004 Apr; 89(4):1630-5. PubMed ID: 15070922
[TBL] [Abstract][Full Text] [Related]
8. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
[TBL] [Abstract][Full Text] [Related]
9. Plasma apelin levels in subjects with nonalcoholic fatty liver disease.
Ercin CN; Dogru T; Tapan S; Kara M; Haymana C; Karadurmus N; Karslioglu Y; Acikel C
Metabolism; 2010 Jul; 59(7):977-81. PubMed ID: 20045153
[TBL] [Abstract][Full Text] [Related]
10. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.
Bugianesi E; Pagotto U; Manini R; Vanni E; Gastaldelli A; de Iasio R; Gentilcore E; Natale S; Cassader M; Rizzetto M; Pasquali R; Marchesini G
J Clin Endocrinol Metab; 2005 Jun; 90(6):3498-504. PubMed ID: 15797948
[TBL] [Abstract][Full Text] [Related]
11. Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease.
Pirgon O; Bilgin H; Tolu I; Odabas D
Clin Endocrinol (Oxf); 2011 Aug; 75(2):189-95. PubMed ID: 21521307
[TBL] [Abstract][Full Text] [Related]
12. Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric banding.
Hanusch-Enserer U; Cauza E; Brabant G; Dunky A; Rosen H; Pacini G; Tüchler H; Prager R; Roden M
J Clin Endocrinol Metab; 2004 Jul; 89(7):3352-8. PubMed ID: 15240614
[TBL] [Abstract][Full Text] [Related]
13. Serum adipokine and ghrelin levels in nonalcoholic steatohepatitis.
Yalniz M; Bahcecioglu IH; Ataseven H; Ustundag B; Ilhan F; Poyrazoglu OK; Erensoy A
Mediators Inflamm; 2006; 2006(6):34295. PubMed ID: 17392582
[TBL] [Abstract][Full Text] [Related]
14. miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease.
Xu Q; Li Y; Shang YF; Wang HL; Yao MX
World J Gastroenterol; 2015 Jan; 21(2):511-6. PubMed ID: 25593466
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin and adiponectin in patients with Cushing's disease before and after successful transsphenoidal surgery.
Libè R; Morpurgo PS; Cappiello V; Maffini A; Bondioni S; Locatelli M; Zavanone M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Jan; 62(1):30-6. PubMed ID: 15638867
[TBL] [Abstract][Full Text] [Related]
16. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels.
Pagotto U; Gambineri A; Vicennati V; Heiman ML; Tschöp M; Pasquali R
J Clin Endocrinol Metab; 2002 Dec; 87(12):5625-9. PubMed ID: 12466363
[TBL] [Abstract][Full Text] [Related]
17. [Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease].
Hu ZW; Guo JW; Deng XL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):853-5. PubMed ID: 16793619
[TBL] [Abstract][Full Text] [Related]
18. The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure.
Marzullo P; Verti B; Savia G; Walker GE; Guzzaloni G; Tagliaferri M; Di Blasio A; Liuzzi A
J Clin Endocrinol Metab; 2004 Feb; 89(2):936-9. PubMed ID: 14764817
[TBL] [Abstract][Full Text] [Related]
19. High ghrelin and obestatin levels and low risk of developing fatty liver.
Gutierrez-Grobe Y; Villalobos-Blasquez I; Sánchez-Lara K; Villa AR; Ponciano-Rodríguez G; Ramos MH; Chavez-Tapia NC; Uribe M; Méndez-Sánchez N
Ann Hepatol; 2010; 9(1):52-7. PubMed ID: 20308723
[TBL] [Abstract][Full Text] [Related]
20. Plasma ghrelin concentrations, food intake, and anorexia in liver failure.
Marchesini G; Bianchi G; Lucidi P; Villanova N; Zoli M; De Feo P
J Clin Endocrinol Metab; 2004 May; 89(5):2136-41. PubMed ID: 15126531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
